Peripheral artery disease. Part 2: medical and endovascular treatment. Nat. Rev. Cardiol. doi:10.1038/nrcardio.2011.81. Article CAS PubMed Google Scholar Belch, J. J. et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch. Intern. Med. 163...
Peripheral artery disease: epidemi- ology and global perspectives. Nat Rev Cardiol. 2017;14(3): 156-170.Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 2017;14:156-70. PUBMED | CROSSREF...
What you need to know Peripheral artery disease affects around 13% of the Western population who are more than 50 years old.1 It is most commonly due to atherosclerosis, where an atherosclerotic plaque causes arterial stenosis or occlusion. This results in a reduction in blood flow to the ...
Peripheral artery disease (PAD) is a major cause of acute and chronic illness, with extremely poor prognosis that remains underdiagnosed and undertreated. Trimethylamine-N-Oxide (TMAO), a gut derived metabolite, has been associated with atherosclerotic burden. We determined plasma levels of TMAO by...
Lower extremity peripheral artery disease: diagnosis and treatment. Am Fam Physician. 2019;99:362–9. PubMed Google Scholar Buso G, Aboyans V, Mazzolai L. Lower extremity artery disease in patients with type 2 diabetes. Eur J Prev Cardiol. 2019;26:114–24. https://doi.org/10.1177/...
Dietary intake of participants with peripheral art... [Angiology. 2011] - PubMed resultWe compared the dietary intake of participants with peripheral artery disease (PAD) and claudication with diet recommendations of the National Cholesterol Education Program (NCEP) and dietary reference intake value...
Efficacy of community-based exercise therapy among African American patients with peripheral artery disease: a randomized clinical trial. JAMA Netw Open. 2019;2(2):e187959. doi:10.1001/jamanetworkopen.2018.7959 ArticlePubMedGoogle Scholar 17. McDermott MM, Guralnik JM, Criqui MH...
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation research. 2015 Apr 24:116(9):1509-26. doi: 10.1161/CIRCRESAHA.116.303849. Epub[PubMed PMID: 25908725] [5] Hodgkiss-Harlow KD, Bandyk DF. Interpretation of arterial duplex testing of lower-extremity arteries and in...
PubMed Google Scholar McDermott MM, Mehta S, Ahn H, Greenland P . Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12: 209–215. CAS PubMed PubMed Central Google Schola...
Plasma levels of fatty acid binding protein 3 (pFABP3) are elevated in patients with peripheral artery disease (PAD). Since the kidney filters FABP3 from circulation, we investigated whether urinary fatty acid binding protein 3 (uFABP3) is associated with PAD, and also explored its potential ...